Correlation Between Orphazyme and TORM Plc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Orphazyme and TORM Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orphazyme and TORM Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orphazyme AS and TORM plc, you can compare the effects of market volatilities on Orphazyme and TORM Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orphazyme with a short position of TORM Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orphazyme and TORM Plc.

Diversification Opportunities for Orphazyme and TORM Plc

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Orphazyme and TORM is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Orphazyme AS and TORM plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TORM plc and Orphazyme is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orphazyme AS are associated (or correlated) with TORM Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TORM plc has no effect on the direction of Orphazyme i.e., Orphazyme and TORM Plc go up and down completely randomly.

Pair Corralation between Orphazyme and TORM Plc

Assuming the 90 days trading horizon Orphazyme AS is expected to generate 2.52 times more return on investment than TORM Plc. However, Orphazyme is 2.52 times more volatile than TORM plc. It trades about 0.03 of its potential returns per unit of risk. TORM plc is currently generating about 0.02 per unit of risk. If you would invest  90,000  in Orphazyme AS on October 10, 2024 and sell it today you would lose (5,000) from holding Orphazyme AS or give up 5.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.98%
ValuesDaily Returns

Orphazyme AS  vs.  TORM plc

 Performance 
       Timeline  
Orphazyme AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orphazyme AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
TORM plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TORM plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Orphazyme and TORM Plc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Orphazyme and TORM Plc

The main advantage of trading using opposite Orphazyme and TORM Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orphazyme position performs unexpectedly, TORM Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TORM Plc will offset losses from the drop in TORM Plc's long position.
The idea behind Orphazyme AS and TORM plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance